LORATADINE - A REAPPRAISAL OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE IN ALLERGIC DISORDERS

被引:124
作者
HARIA, M
FITTON, A
PETERS, DH
机构
[1] Adis International Limited, Auckland, 41 Centorian Drive, Private Bag 65901, Mairangi Bay
关键词
D O I
10.2165/00003495-199448040-00009
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Loratadine is a long-acting antihistamine agent, exhibiting partial selectivity for peripheral histamine H-1-receptors. To date, loratadine has been evaluated in allergic rhinitis, urticaria and, to a limited extent, in asthma. In several large controlled comparative clinical studies, loratadine was superior to placebo, faster acting than astemizole and as effective as azatadine, cetirizine, chlorpheniramine (chlorphenamine), clemastine, hydroxyzine, mequitazine and terfenadine in patients with allergic rhinitis and chronic urticaria. The clinical effectiveness of loratadine in asthma is at present unclear Loratadine is well tolerated. At dosages of 10mg daily, commonly reported adverse events were somnolence, fatigue and headache. Sedation occurred less frequently with loratadine than with azatadine, cetirizine, chlorpheniramine, clemastine and mequitazine. Serious ventricular arrhythmias, as reported with some other second generation histamine H-1-receptor antagonists, have not been observed with loratadine to date. Thus, loratadine, with its attributes of once daily administration, fast onset of action and essentially nonsedating properties, would appear to be an appropriate first-line agent for the treatment of allergic rhinitis or urticaria.
引用
收藏
页码:617 / 637
页数:21
相关论文
共 119 条
[1]  
AFFRIME MB, 1993, ALLERGY S16, V48, P29
[2]   SELECTIVE DISPLACEMENT OF [H-3] MEPYRAMINE FROM PERIPHERAL VS CENTRAL-NERVOUS-SYSTEM RECEPTORS BY LORATADINE, A NONSEDATING ANTIHISTAMINE [J].
AHN, HS ;
BARNETT, A .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 127 (1-2) :153-155
[3]   SUPPRESSIVE EFFECT OF LORATADINE ON ALLERGEN-INDUCED HISTAMINE-RELEASE IN THE NOSE [J].
ANDERSSON, M ;
NOLTE, H ;
BAUMGARTEN, C ;
PIPKORN, U .
ALLERGY, 1991, 46 (07) :540-546
[4]   EVALUATION OF THE CNS PROPERTIES OF SCH-29851, A POTENTIAL NON-SEDATING ANTIHISTAMINE [J].
BARNETT, A ;
IORIO, LC ;
KREUTNER, W ;
TOZZI, S ;
AHN, HS ;
GULBENKIAN, A .
AGENTS AND ACTIONS, 1984, 14 (5-6) :590-597
[5]  
BEDARD PM, 1992, CLIN THER, V14, P268
[6]  
BELAICH S, 1990, ANN ALLERGY, V64, P191
[7]  
BERKOWITZ RB, 1989, ANN ALLERGY, V63, P336
[8]   THE EFFICACY AND SAFETY OF LORATIDINE IN THE MANAGEMENT OF CHRONIC IDIOPATHIC URTICARIA [J].
BERNSTEIN, IL ;
BERNSTEIN, DI .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1988, 81 (01) :211-211
[9]  
BERTHON B, 1993, ALLERGY S16, V48, P190
[10]   EFFICACY AND SAFETY OF LORATADINE SUSPENSION IN THE TREATMENT OF CHILDREN WITH ALLERGIC RHINITIS [J].
BONER, AL ;
MIGLIORANZI, P ;
RICHELLI, C ;
MARCHESI, E ;
ANDREOLI, A .
ALLERGY, 1989, 44 (06) :437-441